The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Maples Kirk R since 2011.
The trader's CIK number is 1504466.
At the time of the last reporting, Maples Kirk R was the SVP, Program Management of Anacor Pharmaceuticals Inc. (stock ticker symbol ANAC).
Also see all insider trading activities at Anacor Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | ANAC | 0 | $0 | 9,660 | $547,933 | 6,060 | $41,935 |
| 2014 | ANAC | 0 | $0 | 113,258 | $3,367,115 | 103,438 | $652,160 |
| 2013 | ANAC | 0 | $0 | 9,652 | $90,592 | 34,782 | $225,735 |
| 2012 | ANAC | 0 | $0 | 52,000 | $311,222 | 0 | $0 |
| 2011 | ANAC | 0 | $0 | 42,368 | $248,818 | 96,020 | $50,609 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-06-01 | ANAC | Sale | 600 | 70.88 | 42,525 |
| 2015-05-12 | ANAC | Option Ex | 6,060 | 6.92 | 41,935 |
| 2015-05-12 | ANAC | Sale | 6,060 | 61.23 | 371,071 |
| 2015-05-01 | ANAC | Sale | 600 | 53.57 | 32,139 |
| 2015-04-01 | ANAC | Sale | 600 | 57.02 | 34,209 |
| 2015-03-02 | ANAC | Sale | 600 | 43.95 | 26,368 |
| 2015-02-02 | ANAC | Sale | 600 | 37.41 | 22,447 |
| 2015-01-02 | ANAC | Sale | 600 | 31.96 | 19,174 |
| 2014-12-09 | ANAC | Option Ex | 60,000 | 6.25 | 375,300 |
| 2014-12-09 | ANAC | Sale | 60,000 | 36.52 | 2,191,380 |
| 2014-12-01 | ANAC | Sale | 600 | 33.64 | 20,182 |
| 2014-11-03 | ANAC | Sale | 600 | 29.09 | 17,457 |
| 2014-10-01 | ANAC | Sale | 600 | 23.85 | 14,311 |
| 2014-09-02 | ANAC | Option Ex | 32,185 | 6.12 | 197,133 |
| 2014-09-02 | ANAC | Sale | 33,879 | 23.32 | 789,956 |
| 2014-08-13 | ANAC | Option Ex | 11,253 | 7.08 | 79,727 |
| 2014-08-13 | ANAC | Sale | 3,959 | 19.96 | 79,013 |
| 2014-06-04 | ANAC | Sale | 1,620 | 14.69 | 23,796 |
| 2014-05-20 | ANAC | Sale | 1,500 | 14.15 | 21,231 |
| 2014-04-21 | ANAC | Sale | 1,500 | 15.60 | 23,397 |
| 2014-03-20 | ANAC | Sale | 3,000 | 22.53 | 67,590 |
| 2014-02-20 | ANAC | Sale | 3,000 | 19.33 | 57,978 |
| 2014-01-21 | ANAC | Sale | 3,000 | 20.27 | 60,824 |
| 2013-12-20 | ANAC | Sale | 3,000 | 16.73 | 50,178 |
| 2013-11-25 | ANAC | Option Ex | 34,782 | 6.49 | 225,735 |
| 2013-08-14 | ANAC | Sale | 1,052 | 9.72 | 10,225 |
| 2013-06-14 | ANAC | Sale | 5,600 | 5.39 | 30,189 |
| 2012-11-26 | ANAC | Sale | 3,000 | 5.22 | 15,666 |
| 2012-11-01 | ANAC | Sale | 3,000 | 5.81 | 17,430 |
| 2012-09-24 | ANAC | Sale | 3,000 | 6.55 | 19,665 |
| 2012-08-27 | ANAC | Sale | 3,000 | 6.17 | 18,498 |
| 2012-07-30 | ANAC | Sale | 3,000 | 6.03 | 18,087 |
| 2012-06-25 | ANAC | Sale | 3,000 | 5.44 | 16,320 |
| 2012-05-29 | ANAC | Sale | 3,000 | 5.34 | 16,025 |
| 2012-04-23 | ANAC | Sale | 3,000 | 5.46 | 16,389 |
| 2012-03-26 | ANAC | Sale | 3,000 | 6.45 | 19,341 |
| 2012-02-27 | ANAC | Sale | 3,000 | 5.90 | 17,694 |
| 2012-01-30 | ANAC | Sale | 3,000 | 7.11 | 21,342 |
| 2012-01-10 | ANAC | Sale | 3,000 | 5.48 | 16,452 |
| 2011-12-30 | ANAC | Sale | 10,000 | 6.14 | 61,449 |
| 2011-12-29 | ANAC | Sale | 6,000 | 6.14 | 36,864 |
| 2011-11-28 | ANAC | Sale | 4,000 | 4.91 | 19,632 |
| 2011-10-31 | ANAC | Sale | 4,000 | 6.65 | 26,592 |
| 2011-09-26 | ANAC | Sale | 4,000 | 5.22 | 20,892 |
| 2011-08-29 | ANAC | Sale | 4,000 | 4.82 | 19,268 |
| 2011-07-25 | ANAC | Sale | 4,000 | 6.16 | 24,656 |
| 2011-06-27 | ANAC | Sale | 4,000 | 6.40 | 25,596 |
| 2011-06-06 | ANAC | Sale | 5,000 | 6.05 | 30,275 |
| 2011-06-01 | ANAC | Sale | 5,000 | 6.00 | 30,000 |
| 2011-05-24 | ANAC | Option Ex | 56,020 | .47 | 26,609 |
| 2011-05-25 | ANAC | Option Ex | 40,000 | .60 | 24,000 |
| 2011-05-24 | ANAC | Sale | 4,592 | 6.00 | 27,552 |
| 2011-05-25 | ANAC | Sale | 3,776 | 6.45 | 24,355 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Maples Kirk R (SVP, Program Management of Anacor Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.